Prabhakar Mujagond

机构：Meril Life Sciences (India) · ORCID：0000-0003-3180-5242

发表论文 10 篇 · 总被引 1344 次 · h-index 7

代表论文

• Regional variation limits applications of healthy gut microbiome reference ranges and disease models (2018 · Nature Medicine · 被引 1001)
• Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis (2018 · Microbiome · 被引 192)
• DeSUMOylase SENP7-Mediated Epithelial Signaling Triggers Intestinal Inflammation via Expansion of Gamma-Delta T Cells (2019 · Cell Reports · 被引 44)
• Non-nucleatum Fusobacterium species are dominant in the Southern Chinese population with distinctive correlations to host diseases compared with F. nucleatum (2020 · Gut · 被引 37)
• Author Correction: Regional variation limits applications of healthy gut microbiome reference ranges and disease models (2018 · Nature Medicine · 被引 35)
• Super-Enhancer-Associated Long Non-Coding RNA LINC01485 Promotes Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells by Regulating MiR-619-5p/RUNX2 Axis (2022 · Frontiers in Endocrinology · 被引 13)